MetaVia Inc.

MetaVia Inc.

MTVA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.56M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MetaVia Inc.MetaVia Inc.-0.4--651%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$8.56 Million
Enterprise Value$-53,469.00
Earnings per Share$-7.35
Beta0.96
Outstanding Shares6,679,250

Return

Return on Equity-650.85%ROE
Return on Assets-164.25%
Return on Invested Capital-648.64%

Valuation & Multiples

P/E Ratio-0.4P/E Ratio
PEG-1.09PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0
Enterprise Value to Net Income0
Total Debt to Enterprise-2.99
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2026
EPS
-$0.69
Est. -$0.73
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 25, 2027
EPS Estimate
-$0.96
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.53%▼ 1.35%
Total Invested$328,434▼ 20.67%
Investors Holding13▼ 4.00%

About NeuroBo Pharmaceuticals Inc

8 employees
CEO: Hyung Heon Kim

Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading inv...